All variants in the LDLR gene

Information The variants shown are described using the NM_000527.4 transcript reference sequence.

4 entries on 1 page. Showing entries 1 - 4.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Enzyme activity     

Predict-BioInf     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     
+?/+? 6 c.902A>G r.(?) p.(Asp301Gly) LDL-receptor class A7 Reduced levels LDL-binding and LDL internalization PolyphenII: probably damaging, 0.999, HumVar probably damaging, 0.997; SIFT: Not tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 0.625 (Ch, Rh, D, P, B, M, Ra, H, Rb, X, Z, S) ACGS likely pathogenic g.11218152A>G g.11107476A>G D280G; FH Greece-3 - LDLR_001860 predicted ligand binding defect; Normal expression, reduced LDL-binding and LDL uptake in vitro therefore ligand binding defective {PMID25545329:Etxebarria et al, Atherosclerosis; 2015 Feb;238(2):304-12}; Segregation reported {PMID25463123: Mollaki et al Atherosclerosis; 2014 Dec;237(2):798-804}. PubMed: Chaves 2001 - - Germline - not in ExAC, May 2015 - - - Sarah Leigh
+?/+? 6 c.902A>G r.(?) p.(Asp301Gly) LDL-receptor class A7 Reduced levels LDL-binding and LDL internalization PolyphenII: probably damaging, 0.999, HumVar probably damaging, 0.997; SIFT: Not tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 0.625 (Ch, Rh, D, P, B, M, Ra, H, Rb, X, Z, S) ACGS likely pathogenic g.11218152A>G g.11107476A>G D280G; FH Greece-3 - LDLR_001860 predicted ligand binding defect; Normal expression, reduced LDL-binding and LDL uptake in vitro therefore ligand binding defective {PMID25545329:Etxebarria et al, Atherosclerosis; 2015 Feb;238(2):304-12}; Segregation reported {PMID25463123: Mollaki et al Atherosclerosis; 2014 Dec;237(2):798-804}. PubMed: Fouchier 2005 - - Germline - not in ExAC, May 2015 - - - Sarah Leigh
+?/+? 6 c.902A>G r.(?) p.(Asp301Gly) LDL-receptor class A7 Reduced levels LDL-binding and LDL internalization PolyphenII: probably damaging, 0.999, HumVar probably damaging, 0.997; SIFT: Not tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 0.625 (Ch, Rh, D, P, B, M, Ra, H, Rb, X, Z, S) ACGS likely pathogenic g.11218152A>G g.11107476A>G D280G; FH Greece-3 - LDLR_001860 predicted ligand binding defect; Normal expression, reduced LDL-binding and LDL uptake in vitro therefore ligand binding defective {PMID25545329:Etxebarria et al, Atherosclerosis; 2015 Feb;238(2):304-12}; Segregation reported {PMID25463123: Mollaki et al Atherosclerosis; 2014 Dec;237(2):798-804}. PubMed: Mavroidis 1997 - - Germline - not in ExAC, May 2015 - - - Sarah Leigh
+/. - c.902A>G r.(?) p.(Asp301Gly) - - - - pathogenic g.11218152A>G g.11107476A>G LDLR(NM_000527.5):c.902A>G (p.D301G) - LDLR_001860 VKGL data sharing initiative Nederland - - - CLASSIFICATION record - - - - - VKGL-NL_AMC
Legend   How to query